Patent Assignment
Reel/Frame 045748/0843
Confirmatory License
Recorded: 2018-03-28
Pages: 2
Assignor
IMMUNOMEDICS, INC.
Executed: 2018-03-23
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Therapy for Metastatic Urothelial Cancer with the Antibody-Drug Conjugate, Sacituzumab Govitecan (Immu-132)
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.